
Mounjaro is the first and only approved treatment in a different class of medication for type 2 diabetes.*
*It works differently than other type 2 diabetes medications by directly activating GIP and GLP-1 pathways to help regulate blood sugar.
GIP=glucose-dependent insulinotropic polypeptide; GLP-1=glucagon-like peptide-1.
What is Mounjaro?
Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus.
It is not known if Mounjaro can be used in people who have had pancreatitis. Mounjaro is not for use in people with type 1 diabetes. It is not known if Mounjaro is safe and effective for use in children under 18 years of age.
Mounjaro for type 2 diabetes
†In studies with or without other diabetes medications, the percentage of people taking Mounjaro who reached an A1C of less than 7% ranged from 75% (5 mg) to 90% (10 mg). People had an average starting A1C of 7.9% to 8.6% across the 5-mg, 10-mg, and 15-mg doses. A 40-week study was conducted to see if Mounjaro 5-mg, 10-mg, and 15-mg plus a basal insulin worked better than basal insulin alone. 90% of people taking Mounjaro 10-mg plus basal insulin achieved an A1C of under 7%.
Select Safety Information
Mounjaro can cause serious side effects, including:
Inflammation of your pancreas (pancreatitis). Stop using Mounjaro and call your healthcare provider right away if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back.
Mounjaro is not a weight loss drug.
‡Individual results may vary. In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).
Select Safety Information
Low blood sugar (hypoglycemia). Your risk for getting low blood sugar may be higher if you use Mounjaro with another medicine that can cause low blood sugar, such as a sulfonylurea or insulin. Signs and symptoms of low blood sugar may include dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, fast heartbeat, anxiety, irritability, or mood changes, hunger, weakness, and feeling jittery.
Talk to your doctor about Mounjaro at your next visit
How Mounjaro works
Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus.
It is not known if Mounjaro can be used in people who have had pancreatitis. Mounjaro is not for use in people with type 1 diabetes. It is not known if Mounjaro is safe and effective for use in children under 18 years of age.
Mounjaro helps your body both regulate blood sugar and decrease how much food you eat
Mounjaro is not a weight loss drug.
It may start working to lower blood sugar from the first dose
The 2.5 mg starting dose is not meant for blood sugar control.
Mounjaro works in multiple ways. It helps:
THE BODY RELEASE INSULIN WHEN BLOOD SUGAR IS HIGH
THE BODY REMOVE EXCESS SUGAR FROM THE BLOOD
STOP THE LIVER FROM MAKING AND RELEASING TOO MUCH SUGAR
REDUCE HOW MUCH FOOD IS EATEN
SLOW DOWN HOW QUICKLY FOOD LEAVES THE STOMACH. THIS LESSENS OVER TIME
You can learn about possible side effects of Mounjaro here.
Select Safety Information
Serious allergic reactions. Stop using Mounjaro and get medical help right away if you have any symptoms of a serious allergic reaction, including:
swelling of your face, lips, tongue or throat, problems breathing or swallowing, severe rash or itching, fainting or feeling dizzy, and very rapid heartbeat.
LillyDirect: Connect to Care
Get speed, convenience, and access to focused care with independent telehealth or in-person providers through LillyDirect.
Get StartedLillyDirect™ is a trademark owned or licensed by Eli Lilly and Company, its subsidiaries or affiliates. All rights reserved.

Mounjaro Savings
We want to help. You may pay as little as $25 for a 1-month or 3-month prescription with the Mounjaro Savings Card.* †
*For eligible commercially insured patients with Mounjaro coverage. Governmental beneficiaries excluded, terms and conditions apply.
†One month is defined as 28 days and 4 pens. Three months is defined as 84 days and up to 12 pens.
LEARN MORESubject to Lilly USA, LLC's (Lilly's) right to terminate, rescind, revoke or amend the Mounjaro Savings Card Program (“Card”) eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason, the Card expires and savings end on 12/31/2023. Card savings are not available to patients without commercial drug insurance or who are enrolled in any state, federal, or government funded healthcare program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medicare Advantage, Medigap, DoD, VA, TRICARE®/CHAMPUS, or any state prescription drug assistance program.
MONTHLY AND ANNUAL MAXIMUM SAVINGS: For patients with commercial drug insurance coverage for Mounjaro: You must have commercial drug insurance that covers Mounjaro and a prescription consistent with FDA-approved product labeling to pay as little as $25 for a 1-month, 2-month, or 3-month prescription fill of Mounjaro. Month is defined as 28-days and up to 4 pens. Card savings are subject to a maximum monthly savings of up to $150 per 1-month prescription, $300 per 2-month prescription, or $450 per 3-month prescription fill and separate maximum annual savings of up to $1800 per calendar year. Subject to Lilly USA, LLC’s (“Lilly”) right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly's sole discretion, without notice, and for any reason, Card expires and savings end on 12/31/2023.
For patients with commercial drug insurance who do not have coverage for Mounjaro: You must have commercial drug insurance that does not cover Mounjaro and a prescription consistent with FDA-approved product labeling to obtain savings of up to $575 off your 1-month prescription fill of Mounjaro. Month is defined as 28-days and up to 4 pens. Card savings are subject to a maximum monthly savings of up to $575 and a separate maximum annual savings of up to $3,450 per calendar year. Subject to Lilly’s right to terminate, rescind, revoke, or amend Card eligibility criteria and/or Card terms and conditions which may occur at Lilly’s sole discretion, without notice, and for any reason, Card expires and savings end on 12/31/2023.
You are responsible for any applicable taxes, fees and any amount that exceeds the monthly or annual maximum benefits. Savings card activation is required. This Card may be terminated, rescinded, revoked, or amended by Lilly at any time without notice and for any reason. Subject to additional terms and conditions. Eligibility criteria and terms and conditions for the Mounjaro Savings Card Program may change from time to time at Lilly’s sole discretion and for any reason; the most current version can be found at https://www.mounjaro.com. Card benefits void where prohibited by law.